Definitive Contract 75N93019C00032
Award Date
8/1/19
Potential Completion Date
10/30/23
Potential Value
$1.5M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Luna Innovations Incorporated
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Roanoke, VA 24011, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
STTR Phase II
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, to Luna Innovations Incorporated. The $223,834.00 contract is for the development of a "FAST-CMV: A POINT-OF-CARE CYTOMEGALOVIRUS SERODIAGNOSTIC AND AVIDITY ASSAY", a diagnostic testing product. The contract has a completion date of July 31, 2018 and was awarded on a firm-fixed-price basis on July...
This is a $1,500,000.00 Firm Fixed Price contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The objective of the contract is to develop cytomegalovirus (CMV) IgG and IgM lateral flow assays required to support a large-scale CMV vaccination trial. Nanocomposix has prior experience providing lateral flow assay devices,...
This is a $222,693 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services. The prime contractor is Zymeron Corporation, a minority-owned small business biotechnology company based in North Carolina. Under this contract, Zymeron will investigate the use of lateral flow immunoassays to rapidly determine the serostatus of individuals for cytomegalovirus (CMV) infections. The...
This is a $224,953.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Luna Innovations Incorporated, a small business manufacturer, under the SBIR program. The contract is for the development and delivery of a "Magnetic Microparticle Kit for Cell Removal from Blood" and has a period of performance ending on August 17, 2016. This contract is for Phase I research and development under the SBIR program, which supports small...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Nanocomposix, Inc., a manufacturer of engineered nanoparticles, to build a proof of concept lateral flow rapid diagnostic to identify the serological status of individuals with respect to cytomegalovirus (CMV). The contract, valued at $224,887.00, requires the contractor to characterize...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase I contract to Qoolabs Inc., a self-certified small disadvantaged business, to develop rapid point-of-care detection tests for serologic status of individuals for cytomegalovirus (CMV) and herpes simplex virus (HSV) infections. The $225,000.00 fixed-price contract has a period of performance through July 31, 2018,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase II contract to Luna Innovations Incorporated, a manufacturer of goods, for the development of "Innovative Oral Formulations for Anti-TB Drugs". The firm-fixed-price contract, with a potential value of $1,499,796.00, was awarded on August 28, 2018, and is set to be completed by November 30, 2020. As a...
This federal contract award, valued at $999,993.00, was issued by the Centers for Disease Control and Prevention (CDC) to Luna Innovations Incorporated, a for-profit manufacturer, for the "PHASE II 010 MULTIPLEX DETECTION OF RECENT AND PRIOR EXPOSURE TO PATHOGENS" project. The contract is a firm fixed price definitive contract with a period of performance ending on March 20, 2023. No set-aside designation was used. The contract involves Luna Innovations developing a nanoSPRi-based...
This is a $299,999.00 Firm Fixed Price Definitive Contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Luna Innovations Incorporated, a small business manufacturer, for the CNT-VECTORED DELIVERY OF MRNA FOR HIV-VACCINES research project under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development and delivery of products and services related to this...
This is a $300,000.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Luna Labs USA LLC, a small business prime contractor, for the AMPFLI: Rapid Nucleic Acid Test for HIV-1 under the Small Business Innovation Research (SBIR) Program Phase I. The contract has a period of performance ending on July 31, 2025. The contract involves the development of a rapid nucleic acid test for HIV-1. Luna Labs USA LLC, a division of...